U.S. prosecutors consider more charges against ex-CEO Shkreli
(Reuters) - Former drug executive Martin Shkreli, who last year became a lightning rod for outrage over soaring prescription drug prices, may face additional U.S. charges of securities fraud, a federal prosecutor said on Tuesday.
No comments:
Post a Comment